Arbutus Biopharma CorpABUS
▲ PositiveCapitalrelevance
Company announces $230M share repurchase tender offer, boosting stock.
Impact on assets 1
Biotech & Genomic Medicine
Arbutus Biopharma CorpArbutus Biopharma plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at $5 to $5.75 per share. The offer is expected to begin on or around August 24 and expire around September 29, with the company using cash on hand to fund the repurchases. Stock rose 12% in Friday premarket trading.
Arbutus Biopharma CorpCompany announces $230M share repurchase tender offer, boosting stock.